Dare Bioscience (DARE) Current Assets (2013 - 2026)
Dare Bioscience's Current Assets was $16.69 million in Q2 2026, up 152.7% from $6.6 million a year earlier.
Powered by 
Analysis
Dare Bioscience (DARE) Current Assets (2013 - 2026) Analysis & Trends
At the end of FY2025, Current Assets at Dare Bioscience came in at $27.06 million, up 46.7% from FY2024.
- Current Assets shows a five-year compound annual growth rate of 31.1% (FY2020 to FY2025).
- In earlier years, Current Assets was $18.45 million in FY2024 (+5.2%), $17.54 million in FY2023 (-59.2%), $43.04 million in FY2022 (-22.2%) and $55.3 million in FY2021 (+691.8%).
- Quarterly Current Assets has moved between $6.6 million (Q2 2025) and $55.3 million (Q4 2021) over five years.
- Compared with a year earlier, Current Assets was higher in five of the last seven quarters, with growth averaging 26.9%.
- The best year-over-year quarter for Current Assets over five years was Q4 2021 (growth of 691.8%); the worst was Q2 2025 (a decline of 68.3%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 64.67 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 59.77 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 33.67 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 36.68 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 27.35 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 27.97 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 34.96 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 13.95 Bn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 41.36 Bn |
| 10 | Dare Bioscience | 10.13 Mn | -55.33 Mn | -132,343.00 | 16.69 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 16.69 Mn |
| Dec 31, 2025 | 27.06 Mn |
| Sep 30, 2025 | 25.00 Mn |
| Jun 30, 2025 | 6.60 Mn |
| Mar 31, 2025 | 11.82 Mn |
| Dec 31, 2024 | 18.45 Mn |
| Sep 30, 2024 | 14.95 Mn |
| Jun 30, 2024 | 20.83 Mn |
| Mar 31, 2024 | 9.98 Mn |
| Dec 31, 2023 | 17.54 Mn |
| Sep 30, 2023 | 22.44 Mn |
| Jun 30, 2023 | 22.24 Mn |
| Mar 31, 2023 | 29.51 Mn |
| Dec 31, 2022 | 43.04 Mn |
| Sep 30, 2022 | 49.57 Mn |
| Jun 30, 2022 | 50.11 Mn |
| Mar 31, 2022 | 47.82 Mn |
| Dec 31, 2021 | 55.30 Mn |
| Sep 30, 2021 | 48.24 Mn |
| Jun 30, 2021 | 14.06 Mn |
API Access
Dare Bioscience Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=DARE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "DARE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=DARE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();